Different strains of Theiler's murine encephalomyelitis virus antagonize different sites in the type I interferon pathway

Journal of Virology

Volumn 84, Issue 18, 2010, Pages 9181-9189

  Stavrou, Spyridon ^a   Feng, Zongdi ^b,c   Lemon, Stanley M ^b,c   Roos, Raymond P ^a  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; INTERFERON; INTERFERON REGULATORY FACTOR 3; MESSENGER RNA; MITOCHONDRIAL ANTIVIRAL SIGNALING PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOVIRUS; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DEMYELINATING DISEASE; ENZYME ACTIVATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; MOUSE; MURINE ENCEPHALOMYELITIS VIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; VIRUS STRAIN; ANIMAL; ANTAGONISTS AND INHIBITORS; IMMUNE EVASION; IMMUNOLOGY; PATHOGENICITY; PATHOLOGY; VIROLOGY;

CARDIOVIRUS; MUS; PICORNAVIRIDAE; THEILER'S ENCEPHALOMYELITIS VIRUS;

ANIMALS; CENTRAL NERVOUS SYSTEM; IMMUNE EVASION; INTERFERON-BETA; MICE; SIGNAL TRANSDUCTION; THEILOVIRUS; VIRAL PROTEINS;

EID: 77956029896     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00603-10     Document Type: Article

References (55)

1. Baechler, E. C., J. W. Bauer, C. A. Slattery, W. A. Ortmann, K. J. Espe, J. Novitzke, S. R. Ytterberg, P. K. Gregersen, T. W. Behrens, and A. M. Reed. 2007. An interferon signature in the peripheral blood of dermatomyositis patients is associated with disease activity. Mol. Med. 13:59-68.
2. Barral, P. M., J. M. Morrison, J. Drahos, P. Gupta, D. Sarkar, P. B. Fisher, and V. R. Racaniello. 2007. MDA-5 is cleaved in poliovirus-infected cells. J. Virol. 81:3677-3684.
3. Bennett, L., A. K. Palucka, E. Arce, V. Cantrell, J. Borvak, J. Banchereau, and V. Pascual. 2003. Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J. Exp. Med. 197:711-723.
4. Biron, C. A. 2001. Interferons alpha and beta as immune regulators - a new look. Immunity 14:661-664.
5. Calenoff, M. A., C. S. Badshah, M. C. Dal Canto, H. L. Lipton, and M. K. Rundell. 1995. The leader polypeptide of Theiler's virus is essential for neurovirulence but not for virus growth in BHK cells. J. Virol. 69:5544-5549.
6. Cash, E., M. Chamorro, and M. Brahic. 1985. Theiler's virus RNA and protein synthesis in the central nervous system of demyelinating mice. Virology 144:290-294. (Pubitemid 15226192)
7. Chen, H. H., W. P. Kong, and R. P. Roos. 1995. The leader peptide of Theiler's murine encephalomyelitis virus is a zinc-binding protein. J. Virol. 69:8076-8078.
8. Chen, H. H., W. P. Kong, L. Zhang, P. L. Ward, and R. P. Roos. 1995. A picornaviral protein synthesized out of frame with the polyprotein plays a key role in a virus-induced immune-mediated demyelinating disease. Nat. Med. 1:927-931.
9. Chen, Z., R. Rijnbrand, R. K. Jangra, S. G. Devaraj, L. Qu, Y. Ma, S. M. Lemon, and K. Li. 2007. Ubiquitination and proteasomal degradation of interferon regulatory factor-3 induced by Npro from a cytopathic bovine viral diarrhea virus. Virology 366:277-292.
10. Chinsangaram, J., M. E. Piccone, and M. J. Grubman. 1999. Ability of foot-and-mouth disease virus to form plaques in cell culture is associated with suppression of alpha/beta interferon. J. Virol. 73:9891-9898.
11. Comabella, M., J. D. Lunemann, J. Rio, A. Sanchez, C. Lopez, E. Julia, M. Fernandez, L. Nonell, M. Camina-Tato, F. Deisenhammer, E. Caballero, M. T. Tortola, M. Prinz, X. Montalban, and R. Martin. 2009. A type I interferon signature in monocytes is associated with poor response to interferon-beta in multiple sclerosis. Brain 132:3353-3365.
12. De Jager, P. L., X. Jia, J. Wang, P. I. de Bakker, L. Ottoboni, N. T. Aggarwal, L. Piccio, S. Raychaudhuri, D. Tran, C. Aubin, R. Briskin, S. Romano, S. E. Baranzini, J. L. McCauley, M. A. Pericak-Vance, J. L. Haines, R. A. Gibson, Y. Naeglin, B. Uitdehaag, P. M. Matthews, L. Kappos, C. Polman, W. L. McArdle, D. P. Strachan, D. Evans, A. H. Cross, M. J. Daly, A. Compston, S. J. Sawcer, H. L. Weiner, S. L. Hauser, D. A. Hafler, and J. R. Oksenberg. 2009. Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci. Nat. Genet. 41:776-782.
13. Delhaye, S., V. van Pesch, and T. Michiels. 2004. The leader protein of Theiler's virus interferes with nucleocytoplasmic trafficking of cellular proteins. J. Virol. 78:4357-4362.
14. Ehrhardt, C., C. Kardinal, W. J. Wurzer, T. Wolff, C. von Eichel-Streiber, S. Pleschka, O. Planz, and S. Ludwig. 2004. Rac1 and PAK1 are upstream of IKK-epsilon and TBK-1 in the viral activation of interferon regulatory factor-3. FEBS Lett. 567:230-238.
15. Fan, J., K. N. Son, S. Y. Arslan, Z. Liang, and H. L. Lipton. 2009. Theiler's murine encephalomyelitis virus leader protein is the only nonstructural protein tested that induces apoptosis when transfected into mammalian cells. J. Virol. 83:6546-6553.
16. Fiette, L., C. Aubert, U. Muller, S. Huang, M. Aguet, M. Brahic, and J. F. Bureau. 1995. Theiler's virus infection of 129Sv mice that lack the interferon alpha/beta or interferon gamma receptors. J. Exp. Med. 181:2069-2076.
17. Fitzgerald, K. A., S. M. McWhirter, K. L. Faia, D. C. Rowe, E. Latz, D. T. Golenbock, A. J. Coyle, S. M. Liao, and T. Maniatis. 2003. IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat. Immunol. 4:491-496.
18. Reference deleted.
19. Fu, J., M. Rodriguez, and R. P. Roos. 1990. Strains from both Theiler's virus subgroups encode a determinant for demyelination. J. Virol. 64:6345-6348.
20. Fu, J. L., S. Stein, L. Rosenstein, T. Bodwell, M. Routbort, B. L. Semler, and R. P. Roos. 1990. Neurovirulence determinants of genetically engineered Theiler viruses. Proc. Natl. Acad. Sci. U. S. A. 87:4125-4129.
21. Gitlin, L., W. Barchet, S. Gilfillan, M. Cella, B. Beutler, R. A. Flavell, M. S. Diamond, and M. Colonna. 2006. Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus. Proc. Natl. Acad. Sci. U. S. A. 103:8459-8464.
22. Grandvaux, N., M. J. Servant, B. tenOever, G. C. Sen, S. Balachandran, G. N. Barber, R. Lin, and J. Hiscott. 2002. Transcriptional profiling of interferon regulatory factor 3 target genes: direct involvement in the regulation of interferon-stimulated genes. J. Virol. 76:5532-5539.
23. Hato, S. V., C. Ricour, B. M. Schulte, K. H. Lanke, M. de Bruijni, J. Zoll, W. J. Melchers, T. Michiels, and F. J. van Kuppeveld. 2007. The mengovirus leader protein blocks interferon-alpha/beta gene transcription and inhibits activation of interferon regulatory factor 3. Cell. Microbiol. 9:2921-2930.
24. Hou, W., E. Y. So, and B. S. Kim. 2007. Role of dendritic cells in differential susceptibility to viral demyelinating disease. PLoS Pathog. 3:e124.
25. Jakkula, E., V. Leppa, A. M. Sulonen, T. Varilo, S. Kallio, A. Kemppinen, S. Purcell, K. Koivisto, P. Tienari, M. L. Sumelahti, I. Elovaara, T. Pirttila, M. Reunanen, A. Aromaa, A. B. Oturai, H. B. Sondergaard, H. F. Harbo, I. L. Mero, S. B. Gabriel, D. B. Mirel, S. L. Hauser, L. Kappos, C. Polman, P. L. De Jager, D. A. Hafler, M. J. Daly, A. Palotie, J. Saarela, and L. Peltonen. 2010. Genome-wide association study in a high-risk isolate for multiple sclerosis reveals associated variants in STAT3 gene. Am. J. Hum. Genet. 86:285-291.
26. Jin, Y. H., M. Mohindru, M. H. Kang, A. C. Fuller, B. Kang, D. Gallo, and B. S. Kim. 2007. Differential virus replication, cytokine production, and antigen-presenting function by microglia from susceptible and resistant mice infected with Theiler's virus. J. Virol. 81:11690-11702.
27. Kato, H., O. Takeuchi, S. Sato, M. Yoneyama, M. Yamamoto, K. Matsui, S. Uematsu, A. Jung, T. Kawai, K. J. Ishii, O. Yamaguchi, K. Otsu, T. Tsujimura, C. S. Koh, C. Reis e Sousa, Y. Matsuura, T. Fujita, and S. Akira. 2006. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441:101-105.
28. Kong, W.-P., G. D. Ghadge, and R. P. Roos. 1994. Involvement of cardiovirus leader in host cell-restricted virus expression. Proc. Natl. Acad. Sci. U. S. A. 91:1796-1800.
29. Lin, R., C. Heylbroeck, P. M. Pitha, and J. Hiscott. 1998. Virus-dependent phosphorylation of the IRF-3 transcription factor regulates nuclear translocation, transactivation potential, and proteasome-mediated degradation. Mol. Cell. Biol. 18:2986-2996.
30. Lin, R., Y. Mamane, and J. Hiscott. 1999. Structural and functional analysis of interferon regulatory factor 3: localization of the transactivation and autoinhibitory domains. Mol. Cell. Biol. 19:2465-2474.
31. Matsuzawa, A., P. H. Tseng, S. Vallabhapurapu, J. L. Luo, W. Zhang, H. Wang, D. A. Vignali, E. Gallagher, and M. Karin. 2008. Essential cytoplasmic translocation of a cytokine receptor-assembled signaling complex. Science 321:663-668.
32. Melroe, G. T., L. Silva, P. A. Schaffer, and D. M. Knipe. 2007. Recruitment of activated IRF-3 and CBP/p300 to herpes simplex virus ICP0 nuclear foci: potential role in blocking IFN-beta induction. Virology 360:305-321.
33. Nagai, T., O. Devergne, T. F. Mueller, D. L. Perkins, J. M. van Seventer, and G. A. van Seventer. 2003. Timing of IFN-beta exposure during human dendritic cell maturation and naive Th cell stimulation has contrasting effects on Th1 subset generation: a role for IFN-beta-mediated regulation of IL-12 family cytokines and IL-18 in naive Th cell differentiation. J. Immunol. 171:5233-5243.
34. Nitayaphan, S., M. M. Toth, and R. P. Roos. 1985. Neutralizing monoclonal antibodies to Theiler's murine encephalomyelitis viruses. J. Virol. 53:651-657.
35. Njenga, M. K., M. J. Coenen, N. DeCuir, H. Y. Yeh, and M. Rodriguez. 2000. Short-term treatment with interferon-alpha/beta promotes remyelination, whereas long-term treatment aggravates demyelination in a murine model of multiple sclerosis. J. Neurosci. Res. 59:661-670.
36. Ohara, Y., S. Stein, J. L. Fu, L. Stillman, L. Klaman, and R. P. Roos. 1988. Molecular cloning and sequence determination of DA strain of Theiler's murine encephalomyelitis viruses. Virology 164:245-255.
37. Olson, J. K., and S. D. Miller. 2009. The innate immune response affects the development of the autoimmune response in Theiler's virus-induced demyelinating disease. J. Immunol. 182:5712-5722.
38. Panne, D., S. M. McWhirter, T. Maniatis, and S. C. Harrison. 2007. Interferon regulatory factor 3 is regulated by a dual phosphorylation-dependent switch. J. Biol. Chem. 282:22816-22822.
39. Paul, S., and T. Michiels. 2006. Cardiovirus leader proteins are functionally interchangeable and have evolved to adapt to virus replication fitness. J. Gen. Virol. 87:1237-1246.
40. Porter, F. W., Y. A. Bochkov, A. J. Albee, C. Wiese, and A. C. Palmenberg. 2006. A picornavirus protein interacts with Ran-GTPase and disrupts nucleocytoplasmic transport. Proc. Natl. Acad. Sci. U. S. A. 103:12417-12422.
41. + T cells and viral persistence. J. Virol. 76:2217-2224.
42. Ricour, C., S. Delhaye, S. V. Hato, T. D. Olenyik, B. Michel, F. J. van Kuppeveld, K. E. Gustin, and T. Michiels. 2009. Inhibition of mRNA export and dimerization of interferon regulatory factor 3 by Theiler's virus leader protein. J. Gen. Virol. 90:177-186.
43. Rodriguez, M., and R. P. Roos. 1992. Pathogenesis of early and late disease in mice infected with Theiler's virus, using intratypic recombinant GDVII/DA viruses. J. Virol. 66:217-225.
44. Romanova, L. I., P. V. Lidsky, M. S. Kolesnikova, K. V. Fominykh, A. P. Gmyl, E. V. Sheval, S. V. Hato, F. J. van Kuppeveld, and V. I. Agol. 2009. Antiapoptotic activity of the cardiovirus leader protein, a viral "security" protein. J. Virol. 83:7273-7284.
45. Roos, R. P. 2002. Pathogenesis of Theiler's murine encephalomyelitis virus-induced disease, p. 427-435. In B. L. Semler and E. Wimmer (ed.), Molecular biology of picornaviruses. ASM Press, Washington, DC.
46. Roos, R. P., S. Stein, Y. Ohara, J. L. Fu, and B. L. Semler. 1989. Infectious cDNA clones of the DA strain of Theiler's murine encephalomyelitis virus. J. Virol. 63:5492-5496.
47. Sarasin-Filipowicz, M., X. Wang, M. Yan, F. H. Duong, V. Poli, D. J. Hilton, D. E. Zhang, and M. H. Heim. 2009. Alpha interferon induces long-lasting refractoriness of JAK-STAT signaling in the mouse liver through induction of USP18/UBP43. Mol. Cell. Biol. 29:4841-4851.
48. Servant, M. J., N. Grandvaux, B. R. tenOever, D. Duguay, R. Lin, and J. Hiscott. 2003. Identification of the minimal phosphoacceptor site required for in vivo activation of interferon regulatory factor 3 in response to virus and double-stranded RNA. J. Biol. Chem. 278:9441-9447.
49. Siu, K. L., K. H. Kok, M. H. Ng, V. K. Poon, K. Y. Yuen, B. J. Zheng, and D. Y. Jin. 2009. Severe acute respiratory syndrome coronavirus M protein inhibits type I interferon production by impeding the formation of TRAF3.TANK.TBK1/IKKepsilon complex. J. Biol. Chem. 284:16202-16209.
50. van Baarsen, L. G., T. C. van der Pouw Kraan, J. J. Kragt, J. M. Baggen, F. Rustenburg, T. Hooper, J. F. Meilof, M. J. Fero, C. D. Dijkstra, C. H. Polman, and C. L. Verweij. 2006. A subtype of multiple sclerosis defined by an activated immune defense program. Genes Immun. 7:522-531.
51. van Baarsen, L. G., S. Vosslamber, M. Tijssen, J. M. Baggen, L. F. van der Voort, J. Killestein, T. C. van der Pouw Kraan, C. H. Polman, and C. L. Verweij. 2008. Pharmacogenomics of interferon-beta therapy in multiple sclerosis: baseline IFN signature determines pharmacological differences between patients. PLoS One 3:e1927.
52. van der Knaap, M. S., J. C. Pronk, and G. C. Scheper. 2006. Vanishing white matter disease. Lancet Neurol. 5:413-423.
53. van Pesch, V., O. van Eyll, and T. Michiels. 2001. The leader protein of Theiler's virus inhibits immediate-early alpha/beta interferon production. J. Virol. 75:7811-7817.
54. Weiner, H. L. 2009. The challenge of multiple sclerosis: how do we cure a chronic heterogeneous disease? Ann. Neurol. 65:239-248.
55. Yang, Y., Y. Liang, L. Qu, Z. Chen, M. Yi, K. Li, and S. M. Lemon. 2007. Disruption of innate immunity due to mitochondrial targeting of a picornaviral protease precursor. Proc. Natl. Acad. Sci. U. S. A. 104:7253-7258.